Findlay Park Partners LLP Danaher Corp Transaction History

Findlay Park Partners LLP

$9.71 Billion
Q3 2024

A detailed history of Findlay Park Partners LLP transactions in Danaher Corp stock. As of the latest transaction made, Findlay Park Partners LLP holds 413,000 shares of DHR stock, worth $94.4 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

413,000

Holding current value

$94.4 Million

% of portfolio

1.18%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$239.25 - $280.76 $98.8 Million - $116 Million	413,000 New	413,000 $115 Million
Q4 2023 Feb 07, 2024	SELL	$185.1 - $233.13 $27.2 Million - $34.2 Million	-146,859 Reduced 36.28%	257,984 $59.7 Million
Q3 2023 Nov 07, 2023	SELL	$233.08 - $265.59 $40 Million - $45.6 Million	-171,556 Reduced 29.76%	404,843 $100 Million
Q2 2023 Aug 04, 2023	SELL	$224.99 - $256.14 $5.8 Million - $6.6 Million	-25,758 Reduced 4.28%	576,399 $138 Million
Q1 2023 May 05, 2023	SELL	$239.75 - $277.0 $7.25 Million - $8.38 Million	-30,258 Reduced 4.78%	602,157 $152 Million
Q4 2022 Feb 06, 2023	SELL	$241.42 - $282.29 $275 Million - $322 Million	-1,140,989 Reduced 64.34%	632,415 $168 Million
Q3 2022 Nov 10, 2022	SELL	$247.06 - $1507.4 $99.1 Million - $604 Million	-400,947 Reduced 18.44%	1,773,404 $458 Million
Q2 2022 Aug 09, 2022	SELL	$237.11 - $299.66 $2.48 Million - $3.13 Million	-10,454 Reduced 0.48%	2,174,351 $551 Million
Q1 2022 May 12, 2022	BUY	$257.27 - $315.76 $68.3 Million - $83.8 Million	265,444 Added 13.83%	2,184,805 $641 Million
Q4 2021 Feb 10, 2022	BUY	$292.08 - $329.01 $114 Million - $128 Million	390,113 Added 25.51%	1,919,361 $631 Million
Q3 2021 Nov 12, 2021	BUY	$272.21 - $332.43 $4.45 Million - $5.43 Million	16,337 Added 1.08%	1,529,248 $466 Million
Q2 2021 Aug 09, 2021	SELL	$225.08 - $271.69 $8.23 Million - $9.93 Million	-36,564 Reduced 2.36%	1,512,911 $406 Million
Q1 2021 May 14, 2021	SELL	$212.38 - $245.9 $45.4 Million - $52.5 Million	-213,575 Reduced 12.11%	1,549,475 $349 Million
Q4 2020 Feb 11, 2021	SELL	$212.5 - $245.46 $159 Million - $183 Million	-745,938 Reduced 29.73%	1,763,050 $392 Million
Q3 2020 Nov 10, 2020	SELL	$177.16 - $215.33 $46.2 Million - $56.2 Million	-261,012 Reduced 9.42%	2,508,988 $540 Million
Q2 2020 Aug 13, 2020	SELL	$128.7 - $176.83 $83.7 Million - $115 Million	-650,000 Reduced 19.01%	2,770,000 $490 Million
Q1 2020 May 14, 2020	SELL	$121.39 - $169.05 $14.1 Million - $19.7 Million	-116,350 Reduced 3.29%	3,420,000 $473 Million
Q4 2019 Feb 12, 2020	SELL	$133.47 - $153.48 $48.2 Million - $55.5 Million	-361,321 Reduced 9.27%	3,536,350 $543 Million
Q3 2019 Nov 05, 2019	SELL	$135.4 - $146.47 $33.9 Million - $36.6 Million	-250,000 Reduced 6.03%	3,897,671 $563 Million
Q2 2019 Aug 07, 2019	SELL	$124.88 - $143.73 $60.9 Million - $70 Million	-487,329 Reduced 10.51%	4,147,671 $593 Million
Q1 2019 May 03, 2019	BUY	$97.62 - $132.29 $3.9 Million - $5.29 Million	40,000 Added 0.87%	4,635,000 $612 Million
Q4 2018 Feb 12, 2019	BUY	$94.85 - $109.54 $87.3 Million - $101 Million	920,000 Added 25.03%	4,595,000 $474 Million
Q3 2018 Nov 07, 2018	SELL	$98.13 - $108.9 $14.7 Million - $16.3 Million	-150,000 Reduced 3.92%	3,675,000 $399 Million
Q2 2018 Aug 07, 2018	BUY	$96.1 - $103.24 $16.8 Million - $18.1 Million	175,000 Added 4.79%	3,825,000 $377 Million
Q1 2018 May 09, 2018	SELL	$92.16 - $103.8 $43.1 Million - $48.5 Million	-467,348 Reduced 11.35%	3,650,000 $357 Million
Q3 2017 Nov 08, 2017	BUY	$79.29 - $88.45 $326 Million - $364 Million	4,117,348	4,117,348 $353 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

539M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $166B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Findlay Park Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Findlay Park Partners LLP with notifications on news.

Account

Findlay Park Partners LLP Danaher Corp Transaction History